(S)-1-Pyrrolidin-2-hydroxymethyl-2-(N-Cbz-N-methyl)amino-ethane, 97.0%, 250mg

4-Methanesulfonylacetophenone, 98.0%, 25g

2-(3-Fluorophenyl)-2-methylpropanoic acid, 95.0%, 5g

4-Benzylpiperidine, 97.0%, 100g

(4-(Cyclopropylsulfonyl)phenyl)boronic acid, 95.0%, 1g

1-Bromo-4-(difluoromethoxy)-2-fluorobenzene, 98%, 5g

2-Bromo-5-hydroxy-benzaldehyde, 97.0%, 25g

Butanedioic acid, 2-hydroxy-, (2S)-, compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1), 99%, 25g

cis-1,2-Cyclohexanediamine>97.0%(GC)(T)25g

(2S,3S)-1-(tert-Butoxycarbonyl)-3-hydroxypyrrolidine-2-carboxylic acid, 95.0%, 5g

2-Iodoaniline>98.0%(GC)(T)25g

N-(4-methylphenyl)methanesulfonamide, 95.0%, 250mg

(3-((2-Bromophenyl)carbamoyl)phenyl)boronic acid, 98%, 10g